About Themis Medicare Limited
Data last updated: 15 July 2026
Themis Medicare Limited is a public limited company based in Vapi, Gujarat, India. It specialises in api manufacturers, a part of the broader pharmaceuticals sector. Incorporated on 31 May 1969, the company has been in operation for over 57 years.
Registered with ROC Ahmedabad under CIN L24110GJ1969PLC001590. Listed on BSE: 530199 and NSE: THEMISMED.
Capital: an authorised share capital of ₹10 Cr and a paid-up capital of ₹9.21 Cr. It is led by directors including Rajneesh Kedarnath Anand and Bhaskar Vemban Iyer.
Last AGM: 12 September 2025. Financial statements filed for year ended 31 March 2025. Office: Plot No 69 – A Gidc Ind Estate Dist – Valsad, Vapi, Gujarat, India – 396195.
As per NSE-filed consolidated financials for FY 2026, the company reported a revenue of ₹342.24 Cr, a decline of 15.6% compared to the previous year. The net worth stands at ₹398.58 Cr (down 1% YoY). Total assets are valued at ₹597.91 Cr (up 1.68% YoY).
The company has a workforce of approximately 1,343 employees as per the latest available data. Its group structure includes 2 subsidiaries and 1 joint venture.
The company is associated with 1 brand - Themis Medicare. As per MCA filings, the company has open charges of ₹615.66 Cr and satisfied charges of ₹110.57 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website themismedicare.com.
-
EmailLocked
-
TelephoneLocked
-
Website
-
Social Media
-
Registered AddressPlot No 69 – A Gidc Ind Estate Dist – Valsad, Vapi, Gujarat, India – 396195
-
IndustryPharma, API Manufacturers, Drug Formulation & Development
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Associated Brands with Themis Medicare Limited
Themis Medicare Limited operates one associated brand: Themis Medicare. These brands represent Themis Medicare Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical products for pain management and critical care are manufactured. | themismedicare.com |
Business Activity of Themis Medicare Limited
Themis Medicare Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details for Themis Medicare Limited
Turnover contribution percentages and historical activity changes require an active report plan.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Themis Medicare Limited
Themis Medicare Limited is audited by KRISHAAN AND CO (ICAI peer reviewed, certificate valid till 2027-07-31) for the financial year 2026, as reported in its NSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.
| Name | Financial year | Audit opinion |
|---|---|---|
| KRISHAAN AND CO (ICAI peer reviewed, certificate valid till 2027-07-31) | FY 2026 | Declaration of unmodified opinion |
Board of Directors of Themis Medicare Limited
Themis Medicare Limited is currently managed by 9 directors, with 19 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
Financials of Themis Medicare Limited FY 2026 filings available
Themis Medicare Limited reported revenue of ₹342.24 Cr (down 15.6% YoY) for FY 2026.
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹342.24 Cr | ₹405.51 Cr | ₹381.76 Cr | ₹354.32 Cr | ₹394.61 Cr | ₹230.67 Cr | ₹201.59 Cr |
| Other Income | ₹9.36 Cr | ₹4.67 Cr | ₹4.76 Cr | ₹11.5 Cr | ₹6.54 Cr | ₹3.62 Cr | ₹3.46 Cr |
| Total Income | ₹351.6 Cr | ₹410.18 Cr | ₹386.52 Cr | ₹365.83 Cr | ₹401.16 Cr | ₹234.29 Cr | ₹205.05 Cr |
| Cost of Materials Consumed | ₹57.3 Cr | ₹76.31 Cr | ₹84.67 Cr | ₹96.04 Cr | ₹113.63 Cr | ₹67.92 Cr | ₹51.38 Cr |
| Purchases of Stock-in-Trade | ₹63 Cr | ₹73.67 Cr | ₹53.61 Cr | ₹30.12 Cr | ₹31.45 Cr | ₹11.55 Cr | ₹15.3 Cr |
| Changes in Inventories | ₹9.17 Cr | -₹17.98 Cr | -₹1.57 Cr | -₹7.79 Cr | ₹3.06 Cr | -₹90.29 Lakh | -₹3.49 Cr |
| Employee Benefit Expense | ₹93.52 Cr | ₹96.38 Cr | ₹82.41 Cr | ₹66.15 Cr | ₹51.97 Cr | ₹39.99 Cr | ₹44.28 Cr |
| Finance Costs | ₹10.69 Cr | ₹10.04 Cr | ₹9.38 Cr | ₹9.56 Cr | ₹8.77 Cr | ₹12.71 Cr | ₹12.88 Cr |
| Depreciation & Amortisation | ₹10.32 Cr | ₹9.93 Cr | ₹12.25 Cr | ₹10.49 Cr | ₹9.48 Cr | ₹8.55 Cr | ₹8.27 Cr |
| Other Expenses | ₹118.85 Cr | ₹128.1 Cr | ₹111.13 Cr | ₹102.36 Cr | ₹98.87 Cr | ₹62.61 Cr | ₹58.47 Cr |
| Total Expenses | ₹362.85 Cr | ₹376.43 Cr | ₹351.88 Cr | ₹306.93 Cr | ₹317.23 Cr | ₹202.44 Cr | ₹187.08 Cr |
| Profit Before Exceptional Items & Tax | -₹11.25 Cr | ₹33.75 Cr | ₹34.64 Cr | ₹58.9 Cr | ₹83.92 Cr | ₹31.86 Cr | ₹17.97 Cr |
| Exceptional Items | -₹86.53 Lakh | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | -₹12.12 Cr | ₹33.75 Cr | ₹34.64 Cr | ₹58.9 Cr | ₹83.92 Cr | ₹31.86 Cr | ₹17.97 Cr |
| Total Tax Expense | ₹78.45 Lakh | ₹9.84 Cr | ₹9.92 Cr | ₹15.61 Cr | ₹22.38 Cr | ₹5.63 Cr | ₹2.09 Cr |
| Net Profit | ₹1.14 Cr | ₹29.83 Cr | ₹43.52 Cr | ₹56.9 Cr | ₹72.88 Cr | ₹35.7 Cr | ₹24.78 Cr |
| attributable to Owners | ₹1.14 Cr | ₹29.83 Cr | ₹43.52 Cr | ₹56.9 Cr | ₹72.88 Cr | ₹35.7 Cr | ₹24.78 Cr |
| attributable to NCI | -₹2,000 | -₹2,000 | -₹3,000 | -₹2,000 | -₹1,000 | -₹1,000 | -₹1,000 |
| Other Comprehensive Income | -₹68.75 Lakh | -₹29.65 Lakh | -₹73.96 Lakh | -₹43.14 Lakh | -₹33.82 Lakh | -₹40.71 Lakh | -₹7.13 Lakh |
| Total Comprehensive Income | ₹45.62 Lakh | ₹29.54 Cr | ₹42.78 Cr | ₹56.47 Cr | ₹72.54 Cr | ₹35.3 Cr | ₹24.71 Cr |
| EBITDA (computed) | ₹9.75 Cr | ₹53.72 Cr | ₹56.26 Cr | ₹78.96 Cr | ₹102.18 Cr | ₹53.12 Cr | ₹39.12 Cr |
| Basic EPS | ₹0.12 | ₹3.24 | ₹4.73 | ₹61.83 | ₹79.22 | ₹38.86 | ₹26.97 |
| Diluted EPS | ₹0.12 | ₹3.24 | ₹4.72 | ₹61.73 | ₹79.07 | ₹38.84 | ₹26.97 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Total Assets | ₹597.91 Cr | ₹588.03 Cr | ₹566.42 Cr | ₹513.96 Cr |
| Non-current Assets | ₹292.93 Cr | ₹284.17 Cr | ₹273.25 Cr | ₹249.43 Cr |
| Current Assets | ₹304.98 Cr | ₹303.87 Cr | ₹293.17 Cr | ₹264.53 Cr |
| Property, Plant & Equipment | ₹166.4 Cr | ₹172.03 Cr | ₹167.81 Cr | ₹160.98 Cr |
| Inventories | ₹81.09 Cr | ₹84.31 Cr | ₹70.57 Cr | ₹68.95 Cr |
| Trade Receivables | ₹178.12 Cr | ₹177.1 Cr | ₹177.95 Cr | ₹145.02 Cr |
| Cash & Equivalents | ₹4.54 Cr | ₹6.56 Cr | ₹9.92 Cr | ₹12.55 Cr |
| Equity (Net Worth) | ₹398.58 Cr | ₹402.6 Cr | ₹377.67 Cr | ₹339.44 Cr |
| Equity Share Capital | ₹9.21 Cr | ₹9.2 Cr | ₹9.2 Cr | ₹9.2 Cr |
| Borrowings (Non-current) | ₹21.86 Cr | ₹18.61 Cr | ₹26.77 Cr | ₹28.45 Cr |
| Borrowings (Current) | ₹78.23 Cr | ₹64.38 Cr | ₹69.02 Cr | ₹63.51 Cr |
| Total Debt (computed) | ₹100.09 Cr | ₹82.99 Cr | ₹95.79 Cr | ₹91.96 Cr |
| Current Liabilities | ₹166.16 Cr | ₹156.12 Cr | ₹154.58 Cr | ₹139.13 Cr |
| Total Liabilities | ₹199.33 Cr | ₹185.43 Cr | ₹188.75 Cr | ₹174.51 Cr |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Operating Cash Flow | -₹3.27 Cr | ₹34.71 Cr | ₹14.47 Cr | ₹16.09 Cr | ₹34.39 Cr |
| Investing Cash Flow | -₹2.54 Cr | -₹12.17 Cr | -₹15.95 Cr | -₹23.96 Cr | -₹15.23 Cr |
| Financing Cash Flow | ₹3.79 Cr | -₹25.9 Cr | -₹1.14 Cr | ₹13.62 Lakh | -₹17.55 Cr |
| Capital Expenditure | ₹4.87 Cr | ₹15.43 Cr | ₹18.42 Cr | ₹28.75 Cr | ₹20.27 Cr |
| Free Cash Flow (computed) | -₹8.14 Cr | ₹19.28 Cr | -₹3.95 Cr | -₹12.66 Cr | ₹14.13 Cr |
| Dividends Paid | ₹4.6 Cr | ₹4.6 Cr | ₹4.6 Cr | ₹4.6 Cr | ₹3.96 Cr |
| Net Change in Cash | -₹2.02 Cr | -₹3.36 Cr | -₹2.62 Cr | -₹7.73 Cr | ₹1.62 Cr |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q4 FY24 | Q3 FY24 | Q2 FY24 | Q1 FY24 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹76.53 Cr | ₹90.13 Cr | ₹77.99 Cr | ₹97.58 Cr | ₹71.7 Cr | ₹93.81 Cr | ₹117.01 Cr | ₹122.99 Cr | ₹97.82 Cr | ₹82.51 Cr | ₹104.78 Cr | ₹96.65 Cr |
| Other Income | ₹3.67 Cr | ₹1.28 Cr | ₹3.24 Cr | ₹1.18 Cr | ₹1.55 Cr | ₹1.02 Cr | ₹1.14 Cr | ₹95.85 Lakh | ₹1.1 Cr | ₹56.49 Lakh | ₹2.44 Cr | ₹65.29 Lakh |
| Total Income | ₹80.2 Cr | ₹91.42 Cr | ₹81.23 Cr | ₹98.75 Cr | ₹73.25 Cr | ₹94.83 Cr | ₹118.15 Cr | ₹123.95 Cr | ₹98.92 Cr | ₹83.08 Cr | ₹107.22 Cr | ₹97.3 Cr |
| Cost of Materials Consumed | ₹14.27 Cr | ₹14.5 Cr | ₹16.11 Cr | ₹12.43 Cr | ₹18.98 Cr | ₹12.76 Cr | ₹21.06 Cr | ₹23.52 Cr | ₹21.65 Cr | ₹21.13 Cr | ₹26.18 Cr | ₹15.71 Cr |
| Purchases of Stock-in-Trade | ₹11.46 Cr | ₹11.63 Cr | ₹18.23 Cr | ₹21.68 Cr | ₹16.3 Cr | ₹22.51 Cr | ₹18.12 Cr | ₹16.74 Cr | ₹11.79 Cr | ₹18.11 Cr | ₹13.92 Cr | ₹9.79 Cr |
| Changes in Inventories | -₹1.98 Cr | ₹3.05 Cr | -₹10.19 Cr | ₹18.29 Cr | -₹14.68 Cr | -₹6.77 Cr | ₹2.46 Cr | ₹1.01 Cr | ₹5.78 Cr | -₹12.77 Cr | ₹1.84 Cr | ₹3.57 Cr |
| Employee Benefit Expense | ₹21.06 Cr | ₹22.68 Cr | ₹24.93 Cr | ₹24.85 Cr | ₹25.45 Cr | ₹24.95 Cr | ₹24.38 Cr | ₹21.6 Cr | ₹22.46 Cr | ₹19.92 Cr | ₹19.86 Cr | ₹20.17 Cr |
| Finance Costs | ₹2.7 Cr | ₹2.75 Cr | ₹2.76 Cr | ₹2.47 Cr | ₹2.45 Cr | ₹2.79 Cr | ₹2.44 Cr | ₹2.36 Cr | ₹2.16 Cr | ₹2.68 Cr | ₹2.04 Cr | ₹2.49 Cr |
| Depreciation & Amortisation | ₹2.6 Cr | ₹2.59 Cr | ₹2.57 Cr | ₹2.55 Cr | ₹2.53 Cr | ₹2.54 Cr | ₹2.45 Cr | ₹2.41 Cr | ₹3.06 Cr | ₹3.1 Cr | ₹3.07 Cr | ₹3.03 Cr |
| Other Expenses | ₹27.96 Cr | ₹28.48 Cr | ₹32.01 Cr | ₹30.41 Cr | ₹31.45 Cr | ₹31.83 Cr | ₹33.87 Cr | ₹30.95 Cr | ₹26.83 Cr | ₹28.05 Cr | ₹30.58 Cr | ₹25.67 Cr |
| Total Expenses | ₹78.07 Cr | ₹85.68 Cr | ₹86.42 Cr | ₹112.68 Cr | ₹82.47 Cr | ₹90.61 Cr | ₹104.78 Cr | ₹98.58 Cr | ₹93.74 Cr | ₹80.23 Cr | ₹97.48 Cr | ₹80.43 Cr |
| Profit Before Exceptional Items & Tax | ₹2.13 Cr | ₹5.74 Cr | -₹5.19 Cr | -₹13.93 Cr | -₹9.21 Cr | ₹4.22 Cr | ₹13.37 Cr | ₹25.37 Cr | ₹5.18 Cr | ₹2.85 Cr | ₹9.74 Cr | ₹16.88 Cr |
| Exceptional Items | ₹0 | -₹86.53 Lakh | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹2.13 Cr | ₹4.87 Cr | -₹5.19 Cr | -₹13.93 Cr | -₹9.21 Cr | ₹4.22 Cr | ₹13.37 Cr | ₹25.37 Cr | ₹5.18 Cr | ₹2.85 Cr | ₹9.74 Cr | ₹16.88 Cr |
| Total Tax Expense | ₹17.02 Lakh | ₹29.42 Lakh | ₹16.49 Lakh | ₹15.52 Lakh | -₹1.46 Cr | ₹1.14 Cr | ₹3.5 Cr | ₹6.66 Cr | ₹2.11 Cr | ₹85.05 Lakh | ₹2.64 Cr | ₹4.32 Cr |
| Net Profit | ₹8.89 Cr | ₹10.09 Cr | -₹3.62 Cr | -₹14.22 Cr | -₹9.66 Cr | ₹51.93 Lakh | ₹14.29 Cr | ₹24.68 Cr | ₹6.64 Cr | ₹7.37 Cr | ₹11.32 Cr | ₹18.19 Cr |
| attributable to Owners | ₹8.89 Cr | ₹10.09 Cr | -₹3.62 Cr | -₹14.25 Cr | -₹9.66 Cr | ₹51.93 Lakh | ₹0 | ₹24.68 Cr | ₹6.64 Cr | ₹7.37 Cr | ₹11.32 Cr | ₹18.19 Cr |
| attributable to NCI | -₹1,000 | ₹0 | ₹0 | -₹1,000 | -₹1,000 | ₹0 | ₹0 | -₹1,000 | -₹3,000 | ₹0 | ₹0 | ₹0 |
| Other Comprehensive Income | -₹6.04 Lakh | -₹52.51 Lakh | -₹7.41 Lakh | -₹2.8 Lakh | -₹23.06 Lakh | -₹3.84 Lakh | ₹15.86 Lakh | -₹18.61 Lakh | -₹42.49 Lakh | -₹10.48 Lakh | -₹9.81 Lakh | -₹11.18 Lakh |
| Total Comprehensive Income | ₹8.83 Cr | ₹9.57 Cr | -₹3.69 Cr | -₹14.25 Cr | -₹9.9 Cr | ₹48.09 Lakh | ₹14.45 Cr | ₹24.5 Cr | ₹6.22 Cr | ₹7.26 Cr | ₹11.22 Cr | ₹18.08 Cr |
| EBITDA (computed) | ₹7.43 Cr | ₹11.08 Cr | ₹14.88 Lakh | -₹8.91 Cr | -₹4.23 Cr | ₹9.55 Cr | ₹18.27 Cr | ₹30.13 Cr | ₹10.4 Cr | ₹8.63 Cr | ₹14.84 Cr | ₹22.39 Cr |
| Basic EPS | ₹0.96 | ₹1.10 | ₹-0.39 | ₹-1.54 | ₹-1.05 | ₹0.06 | ₹1.55 | ₹2.68 | ₹0.72 | ₹0.80 | ₹12.30 | ₹19.77 |
| Diluted EPS | ₹0.96 | ₹1.09 | ₹-0.39 | ₹-1.54 | ₹-1.05 | ₹0.06 | ₹1.55 | ₹2.68 | ₹0.72 | ₹0.80 | ₹12.28 | ₹19.73 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹342.24 Cr | ₹405.51 Cr | ₹381.76 Cr | ₹354.32 Cr | ₹394.61 Cr | ₹230.67 Cr | ₹201.59 Cr |
| Other Income | ₹9.36 Cr | ₹4.67 Cr | ₹4.76 Cr | ₹11.5 Cr | ₹6.54 Cr | ₹3.62 Cr | ₹3.47 Cr |
| Total Income | ₹351.6 Cr | ₹410.18 Cr | ₹386.52 Cr | ₹365.83 Cr | ₹401.16 Cr | ₹234.29 Cr | ₹205.06 Cr |
| Cost of Materials Consumed | ₹57.3 Cr | ₹76.31 Cr | ₹84.67 Cr | ₹96.04 Cr | ₹113.63 Cr | ₹67.92 Cr | ₹51.38 Cr |
| Purchases of Stock-in-Trade | ₹63 Cr | ₹73.67 Cr | ₹53.61 Cr | ₹30.12 Cr | ₹31.45 Cr | ₹11.55 Cr | ₹15.3 Cr |
| Changes in Inventories | ₹9.17 Cr | -₹17.98 Cr | -₹1.57 Cr | -₹7.79 Cr | ₹3.06 Cr | -₹1.27 Cr | -₹3.49 Cr |
| Employee Benefit Expense | ₹93.52 Cr | ₹96.38 Cr | ₹82.41 Cr | ₹66.15 Cr | ₹51.97 Cr | ₹39.99 Cr | ₹44.28 Cr |
| Finance Costs | ₹10.69 Cr | ₹10.04 Cr | ₹9.38 Cr | ₹9.56 Cr | ₹8.77 Cr | ₹12.71 Cr | ₹12.88 Cr |
| Depreciation & Amortisation | ₹10.32 Cr | ₹9.93 Cr | ₹12.25 Cr | ₹10.49 Cr | ₹9.48 Cr | ₹8.55 Cr | ₹8.27 Cr |
| Other Expenses | ₹118.84 Cr | ₹128.08 Cr | ₹111.1 Cr | ₹102.35 Cr | ₹98.85 Cr | ₹62.59 Cr | ₹58.45 Cr |
| Total Expenses | ₹362.84 Cr | ₹376.42 Cr | ₹351.85 Cr | ₹306.92 Cr | ₹317.22 Cr | ₹202.04 Cr | ₹187.05 Cr |
| Profit Before Exceptional Items & Tax | -₹11.24 Cr | ₹33.76 Cr | ₹34.67 Cr | ₹58.91 Cr | ₹83.94 Cr | ₹32.25 Cr | ₹18.01 Cr |
| Exceptional Items | -₹2.16 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | -₹13.4 Cr | ₹33.76 Cr | ₹34.67 Cr | ₹58.91 Cr | ₹83.94 Cr | ₹32.25 Cr | ₹18.01 Cr |
| Total Tax Expense | ₹78.45 Lakh | ₹9.84 Cr | ₹9.92 Cr | ₹15.61 Cr | ₹22.38 Cr | ₹5.63 Cr | ₹2.09 Cr |
| Net Profit | -₹14.19 Cr | ₹23.92 Cr | ₹24.75 Cr | ₹43.29 Cr | ₹61.56 Cr | ₹26.62 Cr | ₹15.91 Cr |
| Other Comprehensive Income | -₹73.52 Lakh | -₹30.9 Lakh | -₹73.68 Lakh | -₹43.36 Lakh | -₹31.87 Lakh | -₹31.85 Lakh | -₹8.36 Lakh |
| Total Comprehensive Income | -₹14.92 Cr | ₹23.61 Cr | ₹24.01 Cr | ₹42.86 Cr | ₹61.24 Cr | ₹26.3 Cr | ₹15.83 Cr |
| EBITDA (computed) | ₹9.77 Cr | ₹53.73 Cr | ₹56.29 Cr | ₹78.97 Cr | ₹102.19 Cr | ₹53.51 Cr | ₹39.15 Cr |
| Basic EPS | ₹-1.54 | ₹2.60 | ₹2.69 | ₹47.05 | ₹66.91 | ₹28.97 | ₹17.32 |
| Diluted EPS | ₹-1.54 | ₹2.59 | ₹2.68 | ₹46.97 | ₹66.78 | ₹28.97 | ₹17.32 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Total Assets | ₹500.21 Cr | ₹505.65 Cr | ₹489.97 Cr | ₹456.29 Cr |
| Non-current Assets | ₹195.22 Cr | ₹200.5 Cr | ₹195.52 Cr | ₹190.49 Cr |
| Current Assets | ₹304.99 Cr | ₹305.15 Cr | ₹294.44 Cr | ₹265.8 Cr |
| Property, Plant & Equipment | ₹166.4 Cr | ₹172.03 Cr | ₹167.81 Cr | ₹160.97 Cr |
| Inventories | ₹81.09 Cr | ₹84.31 Cr | ₹70.57 Cr | ₹68.95 Cr |
| Trade Receivables | ₹178.12 Cr | ₹177.46 Cr | ₹178.3 Cr | ₹145.38 Cr |
| Cash & Equivalents | ₹4.45 Cr | ₹6.47 Cr | ₹9.83 Cr | ₹12.51 Cr |
| Equity (Net Worth) | ₹300.95 Cr | ₹320.29 Cr | ₹301.28 Cr | ₹281.83 Cr |
| Equity Share Capital | ₹9.21 Cr | ₹9.2 Cr | ₹9.2 Cr | ₹9.2 Cr |
| Borrowings (Non-current) | ₹21.86 Cr | ₹18.61 Cr | ₹26.77 Cr | ₹28.45 Cr |
| Borrowings (Current) | ₹78.23 Cr | ₹64.38 Cr | ₹69.02 Cr | ₹63.51 Cr |
| Total Debt (computed) | ₹100.09 Cr | ₹82.99 Cr | ₹95.79 Cr | ₹91.96 Cr |
| Current Liabilities | ₹166.1 Cr | ₹156.06 Cr | ₹154.52 Cr | ₹139.07 Cr |
| Total Liabilities | ₹199.26 Cr | ₹185.37 Cr | ₹188.69 Cr | ₹174.46 Cr |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Operating Cash Flow | -₹3.27 Cr | ₹34.71 Cr | ₹22.04 Cr | ₹16.07 Cr | ₹34.39 Cr |
| Investing Cash Flow | -₹2.54 Cr | -₹12.17 Cr | -₹15.96 Cr | -₹23.96 Cr | -₹15.58 Cr |
| Financing Cash Flow | ₹3.79 Cr | -₹25.9 Cr | -₹8.77 Cr | ₹13.62 Lakh | -₹17.55 Cr |
| Capital Expenditure | ₹4.87 Cr | ₹15.43 Cr | ₹18.42 Cr | ₹28.75 Cr | ₹20.63 Cr |
| Free Cash Flow (computed) | -₹8.14 Cr | ₹19.28 Cr | ₹3.63 Cr | -₹12.68 Cr | ₹13.77 Cr |
| Dividends Paid | ₹4.6 Cr | ₹4.6 Cr | ₹4.6 Cr | ₹4.6 Cr | ₹3.96 Cr |
| Net Change in Cash | -₹2.02 Cr | -₹3.36 Cr | -₹2.68 Cr | -₹7.75 Cr | ₹1.26 Cr |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q4 FY24 | Q3 FY24 | Q2 FY24 | Q1 FY24 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹76.53 Cr | ₹90.13 Cr | ₹77.99 Cr | ₹97.58 Cr | ₹71.7 Cr | ₹93.81 Cr | ₹99.59 Cr | ₹106.08 Cr | ₹97.82 Cr | ₹82.51 Cr | ₹104.78 Cr | ₹96.65 Cr |
| Other Income | ₹3.67 Cr | ₹1.28 Cr | ₹3.24 Cr | ₹1.18 Cr | ₹1.55 Cr | ₹1.02 Cr | ₹76.61 Lakh | ₹71.17 Lakh | ₹1.1 Cr | ₹56.49 Lakh | ₹2.44 Cr | ₹65.29 Lakh |
| Total Income | ₹80.2 Cr | ₹91.42 Cr | ₹81.23 Cr | ₹98.75 Cr | ₹73.25 Cr | ₹94.83 Cr | ₹100.36 Cr | ₹106.79 Cr | ₹98.92 Cr | ₹83.08 Cr | ₹107.22 Cr | ₹97.3 Cr |
| Cost of Materials Consumed | ₹14.27 Cr | ₹14.5 Cr | ₹16.11 Cr | ₹12.43 Cr | ₹18.98 Cr | ₹12.76 Cr | ₹11.37 Cr | ₹13.3 Cr | ₹21.65 Cr | ₹21.13 Cr | ₹26.18 Cr | ₹15.71 Cr |
| Purchases of Stock-in-Trade | ₹11.46 Cr | ₹11.63 Cr | ₹18.23 Cr | ₹21.68 Cr | ₹16.3 Cr | ₹22.51 Cr | ₹18.12 Cr | ₹16.74 Cr | ₹11.79 Cr | ₹18.11 Cr | ₹13.92 Cr | ₹9.79 Cr |
| Changes in Inventories | -₹1.98 Cr | ₹3.05 Cr | -₹10.19 Cr | ₹18.29 Cr | -₹14.68 Cr | -₹6.77 Cr | ₹2.91 Cr | ₹1.37 Cr | ₹5.78 Cr | -₹12.77 Cr | ₹1.84 Cr | ₹3.57 Cr |
| Employee Benefit Expense | ₹21.06 Cr | ₹22.68 Cr | ₹24.93 Cr | ₹24.85 Cr | ₹25.45 Cr | ₹24.95 Cr | ₹21.59 Cr | ₹18.87 Cr | ₹22.46 Cr | ₹19.92 Cr | ₹19.86 Cr | ₹20.17 Cr |
| Finance Costs | ₹2.7 Cr | ₹2.75 Cr | ₹2.76 Cr | ₹2.47 Cr | ₹2.45 Cr | ₹2.79 Cr | ₹1.6 Cr | ₹1.44 Cr | ₹2.16 Cr | ₹2.68 Cr | ₹2.04 Cr | ₹2.49 Cr |
| Depreciation & Amortisation | ₹2.6 Cr | ₹2.59 Cr | ₹2.57 Cr | ₹2.55 Cr | ₹2.53 Cr | ₹2.54 Cr | ₹1.06 Cr | ₹1.01 Cr | ₹3.06 Cr | ₹3.1 Cr | ₹3.07 Cr | ₹3.03 Cr |
| Other Expenses | ₹27.95 Cr | ₹28.48 Cr | ₹32.01 Cr | ₹30.41 Cr | ₹31.44 Cr | ₹31.83 Cr | ₹28.57 Cr | ₹26.55 Cr | ₹26.82 Cr | ₹28.04 Cr | ₹30.58 Cr | ₹25.66 Cr |
| Total Expenses | ₹78.06 Cr | ₹85.68 Cr | ₹86.42 Cr | ₹112.68 Cr | ₹82.46 Cr | ₹90.61 Cr | ₹85.23 Cr | ₹79.28 Cr | ₹93.72 Cr | ₹80.23 Cr | ₹97.48 Cr | ₹80.42 Cr |
| Profit Before Exceptional Items & Tax | ₹2.14 Cr | ₹5.74 Cr | -₹5.19 Cr | -₹13.92 Cr | -₹9.21 Cr | ₹4.22 Cr | ₹15.13 Cr | ₹27.5 Cr | ₹5.2 Cr | ₹2.85 Cr | ₹9.74 Cr | ₹16.88 Cr |
| Exceptional Items | ₹0 | -₹86.53 Lakh | ₹0 | -₹1.29 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹2.14 Cr | ₹4.87 Cr | -₹5.19 Cr | -₹15.22 Cr | -₹9.21 Cr | ₹4.22 Cr | ₹15.13 Cr | ₹27.5 Cr | ₹5.2 Cr | ₹2.85 Cr | ₹9.74 Cr | ₹16.88 Cr |
| Total Tax Expense | ₹17.02 Lakh | ₹29.42 Lakh | ₹16.49 Lakh | ₹15.52 Lakh | -₹1.46 Cr | ₹1.14 Cr | ₹3.95 Cr | ₹7.2 Cr | ₹2.11 Cr | ₹85.05 Lakh | ₹2.64 Cr | ₹4.32 Cr |
| Net Profit | ₹1.97 Cr | ₹4.58 Cr | -₹5.36 Cr | -₹15.37 Cr | -₹7.74 Cr | ₹3.08 Cr | ₹9.87 Cr | ₹18.71 Cr | ₹3.09 Cr | ₹2 Cr | ₹7.1 Cr | ₹12.56 Cr |
| Other Comprehensive Income | -₹6.13 Lakh | -₹51.94 Lakh | -₹7.72 Lakh | -₹7.73 Lakh | -₹25.2 Lakh | -₹1.9 Lakh | ₹14.62 Lakh | -₹18.42 Lakh | -₹41.17 Lakh | -₹10.83 Lakh | -₹10.85 Lakh | -₹10.83 Lakh |
| Total Comprehensive Income | ₹1.9 Cr | ₹4.06 Cr | -₹5.43 Cr | -₹15.45 Cr | -₹8 Cr | ₹3.06 Cr | ₹10.02 Cr | ₹18.53 Cr | ₹2.68 Cr | ₹1.89 Cr | ₹6.99 Cr | ₹12.45 Cr |
| EBITDA (computed) | ₹7.44 Cr | ₹11.08 Cr | ₹14.88 Lakh | -₹8.9 Cr | -₹4.23 Cr | ₹9.55 Cr | ₹17.79 Cr | ₹29.96 Cr | ₹10.41 Cr | ₹8.63 Cr | ₹14.85 Cr | ₹22.4 Cr |
| Basic EPS | ₹0.21 | ₹0.50 | ₹-0.58 | ₹-1.67 | ₹-0.84 | ₹0.33 | ₹1.22 | ₹2.20 | ₹0.34 | ₹0.22 | ₹7.71 | ₹13.64 |
| Diluted EPS | ₹0.21 | ₹0.50 | ₹-0.58 | ₹-1.67 | ₹-0.84 | ₹0.33 | ₹1.21 | ₹2.20 | ₹0.34 | ₹0.22 | ₹7.70 | ₹13.62 |
Shareholding Pattern of Themis Medicare Limited
As per the shareholding pattern filed with NSE for the quarter ended Mar 2026, promoters hold 67.11%, foreign institutional investors hold 0.11%, domestic institutional investors hold 0.01%, retail and other public shareholders hold 32.78% of Themis Medicare Limited. The company had 21,818 shareholders on record.
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | |
|---|---|---|---|---|---|---|
| Promoters | 67.11% | 67.11% | 67.15% | 67.15% | 67.15% | 67.15% |
| Public | 32.89% | 32.89% | 32.85% | 32.85% | 32.85% | 32.85% |
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 67.11% | 67.15% | 67.15% | 67.16% | 67.18% | 67.26% | 67.27% | 67.32% | 67.32% | 66.99% | 71.11% |
| Public | 32.89% | 32.85% | 32.85% | 32.84% | 32.82% | 32.74% | 32.73% | 32.68% | 32.68% | 33.01% | 28.89% |
| Promoter change (YoY, %pts) | -0.04 | +0.00 | -0.01 | -0.02 | -0.08 | -0.01 | -0.05 | +0.00 | +0.33 | -4.12 | - |
Board & Governance of Themis Medicare Limited
As per the corporate governance filing with NSE for the quarter ended 31-MAR-2026, the board of Themis Medicare Limited has 9 directors - 4 independent and 2 executive. The board is chaired by Dinesh Shantilal Patel.
| Director | Position | On board since | Listed boards |
|---|---|---|---|
| Dinesh Shantilal Patel | Executive Director · Chairperson | 2007-06-29 | 2 |
| Sachin Dinesh Patel | Executive Director · CEO-MD | 2007-06-29 | 2 |
| Rajneesh Kedarnath Anand | Non-Executive - Non Independent Director | 2007-04-27 | 2 |
| Adam Demeter | Non-Executive - Non Independent Director | 2023-09-11 | 1 |
| Reena Sachin Patel | Alternate Director | 2023-09-11 | 1 |
| Bhaskar Vemban Iyer | Non-Executive - Independent Director | 2021-11-12 | 3 |
| Shishir Vasant Dalal | Non-Executive - Independent Director | 2023-09-11 | 3 |
| Nikunt Kirit Raval | Non-Executive - Independent Director | 2024-06-06 | 2 |
| Neha Anant Thakore | Non-Executive - Independent Director | 2025-08-01 | 2 |
| Committee | Members |
|---|---|
| Audit Committee | Shishir Vasant Dalal (Chairperson), Sachin Dinesh Patel, Bhaskar Vemban Iyer, Nikunt Kirit Raval |
| Nomination and remuneration committee | Shishir Vasant Dalal (Chairperson), Rajneesh Kedarnath Anand, Nikunt Kirit Raval |
| Stakeholders Relationship Committee | Nikunt Kirit Raval (Chairperson), Sachin Dinesh Patel, Rajneesh Kedarnath Anand, Bhaskar Vemban Iyer |
| Risk Management Committee | Sachin Dinesh Patel (Chairperson), Bhaskar Vemban Iyer, Neha Anant Thakore, Tushar Dalal |
| Corporate Social Responsibility Committee | Nikunt Kirit Raval (Chairperson), Sachin Dinesh Patel, Neha Anant Thakore |
| Allotment Committee | Dinesh Shantilal Patel (Chairperson), Sachin Dinesh Patel |
Group Structure of Themis Medicare Limited
Themis Medicare Limited has 2 subsidiary companies, 1 joint venture, and 2 associated companies. This group structure data is as of FY 2023. The corporate group structure reflects Themis Medicare Limited's business expansion strategy and organizational complexity.
| Company Name | CIN | Shares Held |
|---|---|---|
| Artemis Biotech Limited | U24233MH2011PLC212359 | - |
| Themis Chemicals Private Limited | U33111MH2010PTC209797 | - |
Showing major subsidiaries. Total: 2.
Charges & Borrowings of Themis Medicare Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 Jun 2026 | Others | ₹4.57 Cr | Open |
| 08 Jun 2026 | Others | ₹15 Cr | Open |
| 31 Dec 2025 | Others | ₹6 Cr | Open |
| 26 Dec 2025 | Others | ₹13 Cr | Open |
| 21 Aug 2025 | Others | ₹1 Cr | Open |
Total charge records: 50 View all charges
Employees and EPFO Compliance at Themis Medicare Limited
Themis Medicare Limited has a workforce of 1,343 employees as of Apr 07, 2024.
Employee and EPFO history for Themis Medicare Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Themis Medicare Limited
GST registrations and filing compliance for Themis Medicare Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Themis Medicare Limited
Credit ratings, litigation, and regulatory alerts for Themis Medicare Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Themis Medicare Limited
MSME payment history for Themis Medicare Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Themis Medicare Limited
Corporate group structure for Themis Medicare Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Themis Medicare Limited
MCA filings and documents for Themis Medicare Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Themis Medicare Limited
Recent News on Themis Medicare Limited
Frequently Asked Questions about Themis Medicare Limited
Themis Medicare Limited is an active public limited company in the pharma sector based in Vapi, Gujarat, India. It was incorporated on 31 May 1969 (57+ years old) and is registered under CIN L24110GJ1969PLC001590. Listed on BSE: 530199 and NSE: THEMISMED. The company has 1,343 employees.
Themis Medicare Limited reported revenue of ₹342.24 Cr for FY 2026 (down 15.6% YoY) based on consolidated NSE filings.
The current directors of Themis Medicare Limited are:
- Rajneesh Kedarnath Anand - Director
- Bhaskar Vemban Iyer - Director
- Dinesh Shantilal Patel - Whole-Time Director
- Sachin Dinesh Patel - Managing Director
- Reena Sachin Patel - Alternate Director
- Neha Anant Thakore - Director
- Nikunt Kirit Raval - Director
- Dr Adam Demeter - Director
- Shishir Vasant Dalal - Director
The primary industry of Themis Medicare Limited is pharma. The company specifically operates in api manufacturers. The company is currently active in this sector.
Yes. Themis Medicare Limited is listed on both BSE (code: 530199) and NSE (symbol: THEMISMED).
Themis Medicare Limited can be reached at the registered office: Plot No 69 – A Gidc Ind Estate Dist – Valsad, Vapi, Gujarat, India – 396195, or through the website themismedicare.com.